Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

about

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

Item

http://www.wikidata.org/entity/Q58790023

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@en

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@nl

type

Item

label

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@en

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@nl

prefLabel

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@en

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@nl

P1476

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy

@en

P2093

Chengfu Dai

http://www.w3.org/2001/XMLSchema#string

Dandan Dong

http://www.w3.org/2001/XMLSchema#string

Jie Luo

http://www.w3.org/2001/XMLSchema#string

Lijiang Hu

http://www.w3.org/2001/XMLSchema#string

Mengyu Liu

http://www.w3.org/2001/XMLSchema#string

Peng Shang

http://www.w3.org/2001/XMLSchema#string

Shenghang Wang

http://www.w3.org/2001/XMLSchema#string

Songlin Peng

http://www.w3.org/2001/XMLSchema#string

Yanwen Fang

http://www.w3.org/2001/XMLSchema#string

Ying Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

Mechanisms of ferroptosis

Bioeffects of static magnetic fields: oxidative stress, genotoxic effects, and cancer studies.

HSPB1 as a novel regulator of ferroptotic cancer cell death

Why do cancers have high aerobic glycolysis?

Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice

Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells

Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice

Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions

P304

1933-1946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416846

http://www.w3.org/2001/XMLSchema#string

P932

6220147

http://www.w3.org/2001/XMLSchema#string